0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pressure Activated Safety Lancets Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-17X18810
Home | Market Reports | Health| Medical Devices & Equipment
Global Pressure Activated Safety Lancets Market Research Report 2024
BUY CHAPTERS

Global Pressure Activated Safety Lancets Market Research Report 2026

Code: QYRE-Auto-17X18810
Report
2026-01-23
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pressure Activated Safety Lancets Market Size

The global Pressure Activated Safety Lancets market was valued at US$ 418 million in 2025 and is anticipated to reach US$ 605 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

Pressure Activated Safety Lancets Market

Pressure Activated Safety Lancets Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pressure Activated Safety Lancets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Pressure Activated Safety Lancets production reached approximately 4,037 M pcs, with an average global market price of around US$ 98 per K pcs.
Pressure Activated Safety Lancets are medical devices used for blood sampling that are designed to automatically activate and puncture the skin when a certain amount of pressure is applied. This eliminates the need for manual activation, reducing the risk of accidental needle sticks and ensuring a consistent and controlled puncture depth. These lancets are commonly used in healthcare settings for patients who require frequent blood tests, providing a safe and efficient method for obtaining blood samples.
In the current healthcare landscape, pressure activated safety lancets have carved out a significant niche within the medical device market. These specialized lancets are designed to enhance the safety of blood sampling procedures, both for patients and healthcare providers.​
The market for pressure activated safety lancets is currently experiencing a period of growth and transformation. Intense competition prevails as multiple manufacturers strive to capture a larger share of this expanding market. New entrants are constantly emerging, often bringing novel features and improved designs. For instance, some companies are focusing on developing lancets with more ergonomic shapes, making them easier to handle for healthcare workers during blood sampling. This competition has compelled established players to innovate continuously. They are investing heavily in research and development to improve the functionality, safety, and user - friendliness of their pressure activated safety lancets.​
Consumers, in this case, both patients and healthcare facilities, have become more discerning. With the spread of information, they are well - aware of the importance of using safe and reliable blood sampling devices. Patients, especially those who require frequent blood tests, demand lancets that cause minimal pain and discomfort. Healthcare facilities, on the other hand, are concerned with the safety of their staff and the prevention of cross - contamination. They look for lancets that are easy to use, can be disposed of safely, and meet stringent quality and safety standards. Brands that fail to meet these expectations risk losing out to competitors.​
The impact of globalization on the pressure activated safety lancet market is also profound. Manufacturers now have access to a global customer base. However, this also means they face competition from all corners of the world. As a result, companies need to adapt to different regulatory environments, cultural attitudes towards healthcare, and market preferences. For example, in some regions, there may be a greater emphasis on cost - effectiveness, while in others, advanced technological features may be more highly valued. Multinational corporations are constantly adjusting their product lines and marketing strategies to suit local markets while maintaining a consistent brand image globally.​
Looking towards the future, several trends are likely to shape the development of the pressure activated safety lancet market. Technological advancements will be a major driving force. The integration of smart technology into these lancets is a distinct possibility. For example, lancets could be designed to connect to mobile apps, allowing patients to record and track their blood test results easily. This would not only enhance the patient experience but also provide valuable data for healthcare providers, enabling more personalized treatment plans.​
Sustainability is another trend that will gain prominence. With increasing environmental concerns, there will be a growing demand for lancets made from eco - friendly materials. Manufacturers will need to focus on reducing waste in the production process and ensuring that the lancets can be disposed of in an environmentally responsible manner. This could involve using biodegradable materials or developing recycling programs for used lancets.​
The rise of home healthcare will also have a significant impact on the market. As more patients prefer to monitor their health at home, the demand for easy - to - use and safe pressure activated safety lancets for home use will increase. Manufacturers will need to develop products that are specifically tailored to the needs of home users, with clear instructions and user - friendly designs. Additionally, the integration of telemedicine with home blood sampling using these lancets could further revolutionize the way healthcare is delivered, allowing for remote monitoring and diagnosis.​
In conclusion, the market for pressure activated safety lancets is in a dynamic state. The current status is marked by competition, discerning consumers, and globalization. The future holds great potential, with technological advancements, sustainability, and the growth of home healthcare set to redefine the market landscape. Companies that can adapt to these changes and stay ahead of the curve will be the ones to succeed in this evolving market.
This report delivers a comprehensive overview of the global Pressure Activated Safety Lancets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pressure Activated Safety Lancets. The Pressure Activated Safety Lancets market size, estimates, and forecasts are provided in terms of sales volume (M pcs) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pressure Activated Safety Lancets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pressure Activated Safety Lancets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pressure Activated Safety Lancets Market Report

Report Metric Details
Report Name Pressure Activated Safety Lancets Market
Accounted market size in 2025 US$ 418 million
Forecasted market size in 2032 US$ 605 million
CAGR 5.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Safety Lancets with Needle
  • Safety Lancets with Blade
by Application
  • Hospital & Clinics
  • Home
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, BD, ASP Global, Medline, Carelife, McKesson, Acti-Lance, Ambisea, Vitrex Medical, Boen Healthcare, Mhc Medical Products, Dynarex, CNWTC, Cardinal Health, Homeaide Diagnostics, Chengwu Medical Products Factory, Henso Medical, GlucoRx, Apollo Medical Technologies, S2S Global
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Pressure Activated Safety Lancets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Pressure Activated Safety Lancets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Pressure Activated Safety Lancets Market growing?

Ans: The Pressure Activated Safety Lancets Market witnessing a CAGR of 5.5% during the forecast period 2026-2032.

What is the Pressure Activated Safety Lancets Market size in 2032?

Ans: The Pressure Activated Safety Lancets Market size in 2032 will be US$ 605 million.

Who are the main players in the Pressure Activated Safety Lancets Market report?

Ans: The main players in the Pressure Activated Safety Lancets Market are Roche, BD, ASP Global, Medline, Carelife, McKesson, Acti-Lance, Ambisea, Vitrex Medical, Boen Healthcare, Mhc Medical Products, Dynarex, CNWTC, Cardinal Health, Homeaide Diagnostics, Chengwu Medical Products Factory, Henso Medical, GlucoRx, Apollo Medical Technologies, S2S Global

What are the Application segmentation covered in the Pressure Activated Safety Lancets Market report?

Ans: The Applications covered in the Pressure Activated Safety Lancets Market report are Hospital & Clinics, Home, Others

What are the Type segmentation covered in the Pressure Activated Safety Lancets Market report?

Ans: The Types covered in the Pressure Activated Safety Lancets Market report are Safety Lancets with Needle, Safety Lancets with Blade

1 Pressure Activated Safety Lancets Market Overview
1.1 Product Definition
1.2 Pressure Activated Safety Lancets by Type
1.2.1 Global Pressure Activated Safety Lancets Market Value by Type: 2025 vs 2032
1.2.2 Safety Lancets with Needle
1.2.3 Safety Lancets with Blade
1.3 Pressure Activated Safety Lancets by Application
1.3.1 Global Pressure Activated Safety Lancets Market Value by Application: 2025 vs 2032
1.3.2 Hospital & Clinics
1.3.3 Home
1.3.4 Others
1.4 Global Pressure Activated Safety Lancets Market Size Estimates and Forecasts
1.4.1 Global Pressure Activated Safety Lancets Revenue 2021–2032
1.4.2 Global Pressure Activated Safety Lancets Sales 2021–2032
1.4.3 Global Pressure Activated Safety Lancets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pressure Activated Safety Lancets Market Competition by Manufacturers
2.1 Global Pressure Activated Safety Lancets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pressure Activated Safety Lancets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pressure Activated Safety Lancets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pressure Activated Safety Lancets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pressure Activated Safety Lancets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pressure Activated Safety Lancets, Product Types and Applications
2.7 Global Key Manufacturers of Pressure Activated Safety Lancets, Date of Entry into the Industry
2.8 Global Pressure Activated Safety Lancets Market Competitive Situation and Trends
2.8.1 Global Pressure Activated Safety Lancets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pressure Activated Safety Lancets Players Market Share by Revenue
2.8.3 Global Pressure Activated Safety Lancets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pressure Activated Safety Lancets Market Scenario by Region
3.1 Global Pressure Activated Safety Lancets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pressure Activated Safety Lancets Sales by Region: 2021–2032
3.2.1 Global Pressure Activated Safety Lancets Sales by Region: 2021–2026
3.2.2 Global Pressure Activated Safety Lancets Sales by Region: 2027–2032
3.3 Global Pressure Activated Safety Lancets Revenue by Region: 2021–2032
3.3.1 Global Pressure Activated Safety Lancets Revenue by Region: 2021–2026
3.3.2 Global Pressure Activated Safety Lancets Revenue by Region: 2027–2032
3.4 North America Pressure Activated Safety Lancets Market Facts & Figures by Country
3.4.1 North America Pressure Activated Safety Lancets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pressure Activated Safety Lancets Sales by Country (2021–2032)
3.4.3 North America Pressure Activated Safety Lancets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pressure Activated Safety Lancets Market Facts & Figures by Country
3.5.1 Europe Pressure Activated Safety Lancets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pressure Activated Safety Lancets Sales by Country (2021–2032)
3.5.3 Europe Pressure Activated Safety Lancets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pressure Activated Safety Lancets Market Facts & Figures by Region
3.6.1 Asia Pacific Pressure Activated Safety Lancets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pressure Activated Safety Lancets Sales by Region (2021–2032)
3.6.3 Asia Pacific Pressure Activated Safety Lancets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pressure Activated Safety Lancets Market Facts & Figures by Country
3.7.1 Latin America Pressure Activated Safety Lancets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pressure Activated Safety Lancets Sales by Country (2021–2032)
3.7.3 Latin America Pressure Activated Safety Lancets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pressure Activated Safety Lancets Market Facts & Figures by Country
3.8.1 Middle East and Africa Pressure Activated Safety Lancets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pressure Activated Safety Lancets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pressure Activated Safety Lancets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pressure Activated Safety Lancets Sales by Type (2021–2032)
4.1.1 Global Pressure Activated Safety Lancets Sales by Type (2021–2026)
4.1.2 Global Pressure Activated Safety Lancets Sales by Type (2027–2032)
4.1.3 Global Pressure Activated Safety Lancets Sales Market Share by Type (2021–2032)
4.2 Global Pressure Activated Safety Lancets Revenue by Type (2021–2032)
4.2.1 Global Pressure Activated Safety Lancets Revenue by Type (2021–2026)
4.2.2 Global Pressure Activated Safety Lancets Revenue by Type (2027–2032)
4.2.3 Global Pressure Activated Safety Lancets Revenue Market Share by Type (2021–2032)
4.3 Global Pressure Activated Safety Lancets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pressure Activated Safety Lancets Sales by Application (2021–2032)
5.1.1 Global Pressure Activated Safety Lancets Sales by Application (2021–2026)
5.1.2 Global Pressure Activated Safety Lancets Sales by Application (2027–2032)
5.1.3 Global Pressure Activated Safety Lancets Sales Market Share by Application (2021–2032)
5.2 Global Pressure Activated Safety Lancets Revenue by Application (2021–2032)
5.2.1 Global Pressure Activated Safety Lancets Revenue by Application (2021–2026)
5.2.2 Global Pressure Activated Safety Lancets Revenue by Application (2027–2032)
5.2.3 Global Pressure Activated Safety Lancets Revenue Market Share by Application (2021–2032)
5.3 Global Pressure Activated Safety Lancets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Pressure Activated Safety Lancets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 BD
6.2.1 BD Company Information
6.2.2 BD Description and Business Overview
6.2.3 BD Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 BD Pressure Activated Safety Lancets Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 ASP Global
6.3.1 ASP Global Company Information
6.3.2 ASP Global Description and Business Overview
6.3.3 ASP Global Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 ASP Global Pressure Activated Safety Lancets Product Portfolio
6.3.5 ASP Global Recent Developments/Updates
6.4 Medline
6.4.1 Medline Company Information
6.4.2 Medline Description and Business Overview
6.4.3 Medline Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Medline Pressure Activated Safety Lancets Product Portfolio
6.4.5 Medline Recent Developments/Updates
6.5 Carelife
6.5.1 Carelife Company Information
6.5.2 Carelife Description and Business Overview
6.5.3 Carelife Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Carelife Pressure Activated Safety Lancets Product Portfolio
6.5.5 Carelife Recent Developments/Updates
6.6 McKesson
6.6.1 McKesson Company Information
6.6.2 McKesson Description and Business Overview
6.6.3 McKesson Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 McKesson Pressure Activated Safety Lancets Product Portfolio
6.6.5 McKesson Recent Developments/Updates
6.7 Acti-Lance
6.7.1 Acti-Lance Company Information
6.7.2 Acti-Lance Description and Business Overview
6.7.3 Acti-Lance Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Acti-Lance Pressure Activated Safety Lancets Product Portfolio
6.7.5 Acti-Lance Recent Developments/Updates
6.8 Ambisea
6.8.1 Ambisea Company Information
6.8.2 Ambisea Description and Business Overview
6.8.3 Ambisea Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ambisea Pressure Activated Safety Lancets Product Portfolio
6.8.5 Ambisea Recent Developments/Updates
6.9 Vitrex Medical
6.9.1 Vitrex Medical Company Information
6.9.2 Vitrex Medical Description and Business Overview
6.9.3 Vitrex Medical Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Vitrex Medical Pressure Activated Safety Lancets Product Portfolio
6.9.5 Vitrex Medical Recent Developments/Updates
6.10 Boen Healthcare
6.10.1 Boen Healthcare Company Information
6.10.2 Boen Healthcare Description and Business Overview
6.10.3 Boen Healthcare Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Boen Healthcare Pressure Activated Safety Lancets Product Portfolio
6.10.5 Boen Healthcare Recent Developments/Updates
6.11 Mhc Medical Products
6.11.1 Mhc Medical Products Company Information
6.11.2 Mhc Medical Products Description and Business Overview
6.11.3 Mhc Medical Products Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Mhc Medical Products Pressure Activated Safety Lancets Product Portfolio
6.11.5 Mhc Medical Products Recent Developments/Updates
6.12 Dynarex
6.12.1 Dynarex Company Information
6.12.2 Dynarex Description and Business Overview
6.12.3 Dynarex Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Dynarex Pressure Activated Safety Lancets Product Portfolio
6.12.5 Dynarex Recent Developments/Updates
6.13 CNWTC
6.13.1 CNWTC Company Information
6.13.2 CNWTC Description and Business Overview
6.13.3 CNWTC Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 CNWTC Pressure Activated Safety Lancets Product Portfolio
6.13.5 CNWTC Recent Developments/Updates
6.14 Cardinal Health
6.14.1 Cardinal Health Company Information
6.14.2 Cardinal Health Description and Business Overview
6.14.3 Cardinal Health Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Cardinal Health Pressure Activated Safety Lancets Product Portfolio
6.14.5 Cardinal Health Recent Developments/Updates
6.15 Homeaide Diagnostics
6.15.1 Homeaide Diagnostics Company Information
6.15.2 Homeaide Diagnostics Description and Business Overview
6.15.3 Homeaide Diagnostics Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Homeaide Diagnostics Pressure Activated Safety Lancets Product Portfolio
6.15.5 Homeaide Diagnostics Recent Developments/Updates
6.16 Chengwu Medical Products Factory
6.16.1 Chengwu Medical Products Factory Company Information
6.16.2 Chengwu Medical Products Factory Description and Business Overview
6.16.3 Chengwu Medical Products Factory Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Chengwu Medical Products Factory Pressure Activated Safety Lancets Product Portfolio
6.16.5 Chengwu Medical Products Factory Recent Developments/Updates
6.17 Henso Medical
6.17.1 Henso Medical Company Information
6.17.2 Henso Medical Description and Business Overview
6.17.3 Henso Medical Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Henso Medical Pressure Activated Safety Lancets Product Portfolio
6.17.5 Henso Medical Recent Developments/Updates
6.18 GlucoRx
6.18.1 GlucoRx Company Information
6.18.2 GlucoRx Description and Business Overview
6.18.3 GlucoRx Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 GlucoRx Pressure Activated Safety Lancets Product Portfolio
6.18.5 GlucoRx Recent Developments/Updates
6.19 Apollo Medical Technologies
6.19.1 Apollo Medical Technologies Company Information
6.19.2 Apollo Medical Technologies Description and Business Overview
6.19.3 Apollo Medical Technologies Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Apollo Medical Technologies Pressure Activated Safety Lancets Product Portfolio
6.19.5 Apollo Medical Technologies Recent Developments/Updates
6.20 S2S Global
6.20.1 S2S Global Company Information
6.20.2 S2S Global Description and Business Overview
6.20.3 S2S Global Pressure Activated Safety Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 S2S Global Pressure Activated Safety Lancets Product Portfolio
6.20.5 S2S Global Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pressure Activated Safety Lancets Industry Chain Analysis
7.2 Pressure Activated Safety Lancets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pressure Activated Safety Lancets Production Mode & Process Analysis
7.4 Pressure Activated Safety Lancets Sales and Marketing
7.4.1 Pressure Activated Safety Lancets Sales Channels
7.4.2 Pressure Activated Safety Lancets Distributors
7.5 Pressure Activated Safety Lancets Customer Analysis
8 Pressure Activated Safety Lancets Market Dynamics
8.1 Pressure Activated Safety Lancets Industry Trends
8.2 Pressure Activated Safety Lancets Market Drivers
8.3 Pressure Activated Safety Lancets Market Challenges
8.4 Pressure Activated Safety Lancets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pressure Activated Safety Lancets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Pressure Activated Safety Lancets Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Pressure Activated Safety Lancets Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Pressure Activated Safety Lancets Sales (M pcs) of Key Manufacturers (2021–2026)
 Table 5. Global Pressure Activated Safety Lancets Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Pressure Activated Safety Lancets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Pressure Activated Safety Lancets Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Pressure Activated Safety Lancets Average Price (US$/K pcs) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Pressure Activated Safety Lancets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Pressure Activated Safety Lancets, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Pressure Activated Safety Lancets, Product Types and Applications
 Table 12. Global Key Manufacturers of Pressure Activated Safety Lancets, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pressure Activated Safety Lancets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pressure Activated Safety Lancets Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pressure Activated Safety Lancets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Pressure Activated Safety Lancets Sales by Region (M pcs), 2021–2026
 Table 18. Global Pressure Activated Safety Lancets Sales Market Share by Region (2021–2026)
 Table 19. Global Pressure Activated Safety Lancets Sales by Region (M pcs), 2027–2032
 Table 20. Global Pressure Activated Safety Lancets Sales Market Share by Region (2027–2032)
 Table 21. Global Pressure Activated Safety Lancets Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Pressure Activated Safety Lancets Revenue Market Share by Region (2021–2026)
 Table 23. Global Pressure Activated Safety Lancets Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Pressure Activated Safety Lancets Revenue Market Share by Region (2027–2032)
 Table 25. North America Pressure Activated Safety Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Pressure Activated Safety Lancets Sales by Country (M pcs), 2021–2026
 Table 27. North America Pressure Activated Safety Lancets Sales by Country (M pcs), 2027–2032
 Table 28. North America Pressure Activated Safety Lancets Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Pressure Activated Safety Lancets Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Pressure Activated Safety Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Pressure Activated Safety Lancets Sales by Country (M pcs), 2021–2026
 Table 32. Europe Pressure Activated Safety Lancets Sales by Country (M pcs), 2027–2032
 Table 33. Europe Pressure Activated Safety Lancets Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Pressure Activated Safety Lancets Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Pressure Activated Safety Lancets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Pressure Activated Safety Lancets Sales by Region (M pcs), 2021–2026
 Table 37. Asia Pacific Pressure Activated Safety Lancets Sales by Region (M pcs), 2027–2032
 Table 38. Asia Pacific Pressure Activated Safety Lancets Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Pressure Activated Safety Lancets Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Pressure Activated Safety Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Pressure Activated Safety Lancets Sales by Country (M pcs), 2021–2026
 Table 42. Latin America Pressure Activated Safety Lancets Sales by Country (M pcs), 2027–2032
 Table 43. Latin America Pressure Activated Safety Lancets Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Pressure Activated Safety Lancets Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Pressure Activated Safety Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Pressure Activated Safety Lancets Sales by Country (M pcs), 2021–2026
 Table 47. Middle East and Africa Pressure Activated Safety Lancets Sales by Country (M pcs), 2027–2032
 Table 48. Middle East and Africa Pressure Activated Safety Lancets Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Pressure Activated Safety Lancets Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Pressure Activated Safety Lancets Sales (M pcs) by Type (2021–2026)
 Table 51. Global Pressure Activated Safety Lancets Sales (M pcs) by Type (2027–2032)
 Table 52. Global Pressure Activated Safety Lancets Sales Market Share by Type (2021–2026)
 Table 53. Global Pressure Activated Safety Lancets Sales Market Share by Type (2027–2032)
 Table 54. Global Pressure Activated Safety Lancets Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Pressure Activated Safety Lancets Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Pressure Activated Safety Lancets Revenue Market Share by Type (2021–2026)
 Table 57. Global Pressure Activated Safety Lancets Revenue Market Share by Type (2027–2032)
 Table 58. Global Pressure Activated Safety Lancets Price (US$/K pcs) by Type (2021–2026)
 Table 59. Global Pressure Activated Safety Lancets Price (US$/K pcs) by Type (2027–2032)
 Table 60. Global Pressure Activated Safety Lancets Sales (M pcs) by Application (2021–2026)
 Table 61. Global Pressure Activated Safety Lancets Sales (M pcs) by Application (2027–2032)
 Table 62. Global Pressure Activated Safety Lancets Sales Market Share by Application (2021–2026)
 Table 63. Global Pressure Activated Safety Lancets Sales Market Share by Application (2027–2032)
 Table 64. Global Pressure Activated Safety Lancets Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Pressure Activated Safety Lancets Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Pressure Activated Safety Lancets Revenue Market Share by Application (2021–2026)
 Table 67. Global Pressure Activated Safety Lancets Revenue Market Share by Application (2027–2032)
 Table 68. Global Pressure Activated Safety Lancets Price (US$/K pcs) by Application (2021–2026)
 Table 69. Global Pressure Activated Safety Lancets Price (US$/K pcs) by Application (2027–2032)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 73. Roche Pressure Activated Safety Lancets Product
 Table 74. Roche Recent Developments/Updates
 Table 75. BD Company Information
 Table 76. BD Description and Business Overview
 Table 77. BD Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 78. BD Pressure Activated Safety Lancets Product
 Table 79. BD Recent Developments/Updates
 Table 80. ASP Global Company Information
 Table 81. ASP Global Description and Business Overview
 Table 82. ASP Global Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 83. ASP Global Pressure Activated Safety Lancets Product
 Table 84. ASP Global Recent Developments/Updates
 Table 85. Medline Company Information
 Table 86. Medline Description and Business Overview
 Table 87. Medline Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 88. Medline Pressure Activated Safety Lancets Product
 Table 89. Medline Recent Developments/Updates
 Table 90. Carelife Company Information
 Table 91. Carelife Description and Business Overview
 Table 92. Carelife Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 93. Carelife Pressure Activated Safety Lancets Product
 Table 94. Carelife Recent Developments/Updates
 Table 95. McKesson Company Information
 Table 96. McKesson Description and Business Overview
 Table 97. McKesson Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 98. McKesson Pressure Activated Safety Lancets Product
 Table 99. McKesson Recent Developments/Updates
 Table 100. Acti-Lance Company Information
 Table 101. Acti-Lance Description and Business Overview
 Table 102. Acti-Lance Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 103. Acti-Lance Pressure Activated Safety Lancets Product
 Table 104. Acti-Lance Recent Developments/Updates
 Table 105. Ambisea Company Information
 Table 106. Ambisea Description and Business Overview
 Table 107. Ambisea Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 108. Ambisea Pressure Activated Safety Lancets Product
 Table 109. Ambisea Recent Developments/Updates
 Table 110. Vitrex Medical Company Information
 Table 111. Vitrex Medical Description and Business Overview
 Table 112. Vitrex Medical Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 113. Vitrex Medical Pressure Activated Safety Lancets Product
 Table 114. Vitrex Medical Recent Developments/Updates
 Table 115. Boen Healthcare Company Information
 Table 116. Boen Healthcare Description and Business Overview
 Table 117. Boen Healthcare Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 118. Boen Healthcare Pressure Activated Safety Lancets Product
 Table 119. Boen Healthcare Recent Developments/Updates
 Table 120. Mhc Medical Products Company Information
 Table 121. Mhc Medical Products Description and Business Overview
 Table 122. Mhc Medical Products Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 123. Mhc Medical Products Pressure Activated Safety Lancets Product
 Table 124. Mhc Medical Products Recent Developments/Updates
 Table 125. Dynarex Company Information
 Table 126. Dynarex Description and Business Overview
 Table 127. Dynarex Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 128. Dynarex Pressure Activated Safety Lancets Product
 Table 129. Dynarex Recent Developments/Updates
 Table 130. CNWTC Company Information
 Table 131. CNWTC Description and Business Overview
 Table 132. CNWTC Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 133. CNWTC Pressure Activated Safety Lancets Product
 Table 134. CNWTC Recent Developments/Updates
 Table 135. Cardinal Health Company Information
 Table 136. Cardinal Health Description and Business Overview
 Table 137. Cardinal Health Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 138. Cardinal Health Pressure Activated Safety Lancets Product
 Table 139. Cardinal Health Recent Developments/Updates
 Table 140. Homeaide Diagnostics Company Information
 Table 141. Homeaide Diagnostics Description and Business Overview
 Table 142. Homeaide Diagnostics Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 143. Homeaide Diagnostics Pressure Activated Safety Lancets Product
 Table 144. Homeaide Diagnostics Recent Developments/Updates
 Table 145. Chengwu Medical Products Factory Company Information
 Table 146. Chengwu Medical Products Factory Description and Business Overview
 Table 147. Chengwu Medical Products Factory Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 148. Chengwu Medical Products Factory Pressure Activated Safety Lancets Product
 Table 149. Chengwu Medical Products Factory Recent Developments/Updates
 Table 150. Henso Medical Company Information
 Table 151. Henso Medical Description and Business Overview
 Table 152. Henso Medical Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 153. Henso Medical Pressure Activated Safety Lancets Product
 Table 154. Henso Medical Recent Developments/Updates
 Table 155. GlucoRx Company Information
 Table 156. GlucoRx Description and Business Overview
 Table 157. GlucoRx Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 158. GlucoRx Pressure Activated Safety Lancets Product
 Table 159. GlucoRx Recent Developments/Updates
 Table 160. Apollo Medical Technologies Company Information
 Table 161. Apollo Medical Technologies Description and Business Overview
 Table 162. Apollo Medical Technologies Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 163. Apollo Medical Technologies Pressure Activated Safety Lancets Product
 Table 164. Apollo Medical Technologies Recent Developments/Updates
 Table 165. S2S Global Company Information
 Table 166. S2S Global Description and Business Overview
 Table 167. S2S Global Pressure Activated Safety Lancets Sales (M pcs), Revenue (US$ Million), Price (US$/K pcs), and Gross Margin (2021–2026)
 Table 168. S2S Global Pressure Activated Safety Lancets Product
 Table 169. S2S Global Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Pressure Activated Safety Lancets Distributors List
 Table 173. Pressure Activated Safety Lancets Customers List
 Table 174. Pressure Activated Safety Lancets Market Trends
 Table 175. Pressure Activated Safety Lancets Market Drivers
 Table 176. Pressure Activated Safety Lancets Market Challenges
 Table 177. Pressure Activated Safety Lancets Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pressure Activated Safety Lancets
 Figure 2. Global Pressure Activated Safety Lancets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Pressure Activated Safety Lancets Market Share by Type: 2025 & 2032
 Figure 4. Safety Lancets with Needle Product Picture
 Figure 5. Safety Lancets with Blade Product Picture
 Figure 6. Global Pressure Activated Safety Lancets Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Pressure Activated Safety Lancets Market Share by Application: 2025 & 2032
 Figure 8. Hospital & Clinics
 Figure 9. Home
 Figure 10. Others
 Figure 11. Global Pressure Activated Safety Lancets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Pressure Activated Safety Lancets Market Size (US$ Million), 2021–2032
 Figure 13. Global Pressure Activated Safety Lancets Sales (M pcs), 2021–2032
 Figure 14. Global Pressure Activated Safety Lancets Average Price (US$/K pcs), 2021–2032
 Figure 15. Pressure Activated Safety Lancets Report Years Considered
 Figure 16. Pressure Activated Safety Lancets Sales Share by Manufacturers in 2025
 Figure 17. Global Pressure Activated Safety Lancets Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Pressure Activated Safety Lancets Players: Market Share by Revenue in Pressure Activated Safety Lancets in 2025
 Figure 19. Pressure Activated Safety Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Pressure Activated Safety Lancets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Pressure Activated Safety Lancets Sales Market Share by Country (2021–2032)
 Figure 22. North America Pressure Activated Safety Lancets Revenue Market Share by Country (2021–2032)
 Figure 23. United States Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Pressure Activated Safety Lancets Sales Market Share by Country (2021–2032)
 Figure 26. Europe Pressure Activated Safety Lancets Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Pressure Activated Safety Lancets Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Pressure Activated Safety Lancets Revenue Market Share by Region (2021–2032)
 Figure 34. China Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Pressure Activated Safety Lancets Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Pressure Activated Safety Lancets Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Pressure Activated Safety Lancets Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Pressure Activated Safety Lancets Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Pressure Activated Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Pressure Activated Safety Lancets by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Pressure Activated Safety Lancets by Type (2021–2032)
 Figure 54. Global Pressure Activated Safety Lancets Price (US$/K pcs) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Pressure Activated Safety Lancets by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Pressure Activated Safety Lancets by Application (2021–2032)
 Figure 57. Global Pressure Activated Safety Lancets Price (US$/K pcs) by Application (2021–2032)
 Figure 58. Pressure Activated Safety Lancets Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network